Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

602 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.
Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, De Bruyne B, Farhat N, Niess G, Jankovic I, Lazar D, Xu K, Fahy M, Serruys PW, Stone GW. Lansky AJ, et al. Among authors: de bruyne b. JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S62-72. doi: 10.1016/j.jcmg.2012.02.003. JACC Cardiovasc Imaging. 2012. PMID: 22421232 Free article.
Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe).
Serruys PW, di Mario C, Piek J, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Mühlberger V, Danzi G, Peels HO, Ford AJ Jr, Boersma E. Serruys PW, et al. Among authors: de bruyne b. Circulation. 1997 Nov 18;96(10):3369-77. doi: 10.1161/01.cir.96.10.3369. Circulation. 1997. PMID: 9396429 Clinical Trial.
Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial Europe.
Piek JJ, Boersma E, di Mario C, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Mühlberger V, Peels HO, Serruys PW. Piek JJ, et al. Among authors: de bruyne b. Eur Heart J. 2000 Mar;21(6):466-74. doi: 10.1053/euhj.1999.1871. Eur Heart J. 2000. PMID: 10681487
Value of coronary stenotic flow velocity acceleration on the prediction of long-term improvement in functional status after angioplasty.
Albertal M, Regar E, Piek JJ, Van Langenhove G, Carlier SG, Thury A, Sianos G, Boersma E, de Bruyne B, di Mario C, Serruys PW; Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) Study Group. Albertal M, et al. Among authors: de bruyne b. Am Heart J. 2001 Jul;142(1):81-6. doi: 10.1067/mhj.2001.115590. Am Heart J. 2001. PMID: 11431661
Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting.
Albertal M, Van Langenhove G, Regar E, Kay IP, Foley D, Sianos G, Kozuma K, Beijsterveldt T, Carlier SG, Belardi JA, Boersma E, Sousa JE, de Bruyne B, Serruys PW; DEBATE II Study Group. Albertal M, et al. Among authors: de bruyne b. Heart. 2001 Aug;86(2):193-8. doi: 10.1136/heart.86.2.193. Heart. 2001. PMID: 11454840 Free PMC article. Clinical Trial.
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe.
Piek JJ, Boersma E, Voskuil M, di Mario C, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Mühlberger V, Peels HO, Serruys PW; DEBATE study group. Piek JJ, et al. Among authors: de bruyne b. Eur Heart J. 2001 Sep;22(18):1725-32. doi: 10.1053/euhj.2000.2587. Eur Heart J. 2001. PMID: 11511122 Clinical Trial.
Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial.
Valgimigli M, Dawkins K, Macaya C, de Bruyne B, Teiger E, Fajadet J, Gert R, De Servi S, Ramondo A, Wittebols K, Stoll HP, Rademaker TA, Serruys PW. Valgimigli M, et al. Among authors: de bruyne b, de servi s. J Am Coll Cardiol. 2007 Jan 30;49(4):431-41. doi: 10.1016/j.jacc.2006.06.081. Epub 2007 Jan 12. J Am Coll Cardiol. 2007. PMID: 17258088 Free article.
Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.
Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, Ormiston JA. Tanimoto S, et al. Among authors: de bruyne b. Catheter Cardiovasc Interv. 2007 Oct 1;70(4):515-23. doi: 10.1002/ccd.21136. Catheter Cardiovasc Interv. 2007. PMID: 17503509
602 results